Viking Therapeutics, Inc. (0VQA.L) LSE

39.18

+3.7871(+10.70%)

Updated at December 05 06:00AM

Currency In USD

Valuation

Market Cap4.39B
Enterprise Value4.36B
P/E Ratio-18.25
PEG Ratio0.47
Price/Sales Ratio0
Price/Book Ratio6.08
Enterprise/Revenue0
Enterprise/EBITDA-15.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-0.32
Return On Equity-0.29

Income Statement

Revenue0
Revenue/Share0
Gross Profit-346,000
EBITDA-109.52M
Net Income-109.96M
Diluted EPS-1.01

Balance Sheet

Total Cash714.57M
Total Cash/Share0.89
Total Debt755,000
Total Debt/Equity0
Current Ratio28.34
Book Value Per Share6.58

Price History

52-Week Change-22.77
52-Week High99.3
52-Week Low8.79
Moving Average 50 Days38.31
Moving Average 200 Days21.29

Statistics

Average Volume10,491
Shares Outstanding113.03M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A